95 related articles for article (PubMed ID: 26149653)
21. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
[TBL] [Abstract][Full Text] [Related]
22. HDAC5 promotes cell proliferation in human hepatocellular carcinoma by up-regulating Six1 expression.
Feng GW; Dong LD; Shang WJ; Pang XL; Li JF; Liu L; Wang Y
Eur Rev Med Pharmacol Sci; 2014; 18(6):811-6. PubMed ID: 24706304
[TBL] [Abstract][Full Text] [Related]
23. [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
Wang Y; Lu Z; Li Y; Ji D; Zhang P; Liu Q; Yao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1076-9. PubMed ID: 25270212
[TBL] [Abstract][Full Text] [Related]
24. GSN synergies with actin-related transfer molecular chain to promote invasion and metastasis of HCC.
Zhou Y; He M
Clin Transl Oncol; 2023 Feb; 25(2):482-490. PubMed ID: 36192574
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of syntenin enhances hepatoma cell proliferation and invasion: potential roles in human hepatoma.
Liu X; Zhang X; Lv Y; Xiang J; Shi J
Oncol Rep; 2014 Dec; 32(6):2810-6. PubMed ID: 25242117
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
[TBL] [Abstract][Full Text] [Related]
29. High GOLPH3 expression is associated with poor prognosis and invasion of hepatocellular carcinoma.
Li Q; Ma Y; Xu W
Mol Med Rep; 2015 Jun; 11(6):4315-20. PubMed ID: 25634514
[TBL] [Abstract][Full Text] [Related]
30. CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
Xu X; Yamamoto H; Liu G; Ito Y; Ngan CY; Kondo M; Nagano H; Dono K; Sekimoto M; Monden M
Int J Mol Med; 2008 Feb; 21(2):145-52. PubMed ID: 18204780
[TBL] [Abstract][Full Text] [Related]
31. Functional and clinical evidence that TAZ is a candidate oncogene in hepatocellular carcinoma.
Guo Y; Pan Q; Zhang J; Xu X; Liu X; Wang Q; Yi R; Xie X; Yao L; Liu W; Shen L
J Cell Biochem; 2015 Nov; 116(11):2465-75. PubMed ID: 25650113
[TBL] [Abstract][Full Text] [Related]
32. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
33. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T
Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131
[TBL] [Abstract][Full Text] [Related]
34. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
[TBL] [Abstract][Full Text] [Related]
35. Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cells.
Jeon JY; Lee JS; Park ER; Shen YN; Kim MY; Shin HJ; Joo HY; Cho EH; Moon SM; Shin US; Park SH; Han CJ; Choi DW; Gu MB; Kim SB; Lee KH
Oncol Rep; 2018 Jul; 40(1):536-544. PubMed ID: 29749478
[TBL] [Abstract][Full Text] [Related]
36. Targeting the estrogen receptor alpha (ERα)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion.
Xiao Y; Liu G; Sun Y; Gao Y; Ouyang X; Chang C; Gong L; Yeh S
Oncogene; 2020 Mar; 39(12):2493-2508. PubMed ID: 31996784
[TBL] [Abstract][Full Text] [Related]
37. Pokemon and MEF2D co-operationally promote invasion of hepatocellular carcinoma.
Hong X; Hong XY; Li T; He CY
Tumour Biol; 2015 Dec; 36(12):9885-93. PubMed ID: 26164003
[TBL] [Abstract][Full Text] [Related]
38. Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion.
Jin D; Tao J; Li D; Wang Y; Li L; Hu Z; Zhou Z; Chang X; Qu C; Zhang H
Oncotarget; 2015 Oct; 6(32):33523-33. PubMed ID: 26378022
[TBL] [Abstract][Full Text] [Related]
39. Expression of Girdin in primary hepatocellular carcinoma and its effect on cell proliferation and invasion.
Cao K; Lu C; Han S; Zou Q; Li J; Xie D; He S; Yu L; Zhou J; Peng X; Cao P
Int J Clin Exp Pathol; 2015; 8(1):551-9. PubMed ID: 25755745
[TBL] [Abstract][Full Text] [Related]
40. Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.
Fang KP; Dai W; Ren YH; Xu YC; Zhang SM; Qian YB
BMC Cancer; 2016 Jan; 16():45. PubMed ID: 26822056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]